Catalyst Wire Dossier Catalyst Wire Dossier

Tropocells Autologous Platelet-rich Fibrin

· Estar Medical dba Medical Technologies, LTD
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tropocells Autologous Platelet-rich Fibrin, covering 2026-01-06 to 2026-01-06. Get the full timeline:

Most recent: Clinical Trial Update: Using TropoCells(R) Autologous Platelet-Rich Fibrin (PRF) to Treat Chronic Non-Healing Wounds [Phase 2]

See pricing